Yingpeng Huang

466 total citations · 1 hit paper
26 papers, 342 citations indexed

About

Yingpeng Huang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yingpeng Huang has authored 26 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Yingpeng Huang's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Yingpeng Huang is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Yingpeng Huang collaborates with scholars based in China, Australia and Nepal. Yingpeng Huang's co-authors include Weijian Sun, Xian Shen, Mingdong Lu, Liyi Li, Pihong Li, Xiangyang Xue, Leping Li, Xiaohong Chen, Xufeng Lu and Wenhai Deng and has published in prestigious journals such as Advanced Science, Journal of Cellular Physiology and International Journal of Biological Macromolecules.

In The Last Decade

Yingpeng Huang

24 papers receiving 339 citations

Hit Papers

Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cupr... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingpeng Huang China 12 175 95 61 52 47 26 342
Binyuan Yan China 12 215 1.2× 66 0.7× 53 0.9× 51 1.0× 67 1.4× 20 402
Hui Ran China 10 182 1.0× 92 1.0× 87 1.4× 25 0.5× 27 0.6× 21 370
Aimin Huang China 10 129 0.7× 33 0.3× 82 1.3× 61 1.2× 35 0.7× 15 380
Qinsong Zeng China 13 166 0.9× 108 1.1× 71 1.2× 36 0.7× 55 1.2× 23 414
Jian Bi China 14 199 1.1× 53 0.6× 43 0.7× 21 0.4× 22 0.5× 26 505
Zhongjian Yu China 13 252 1.4× 154 1.6× 49 0.8× 49 0.9× 52 1.1× 26 520
Qianmei Wang China 13 147 0.8× 42 0.4× 41 0.7× 26 0.5× 36 0.8× 31 401

Countries citing papers authored by Yingpeng Huang

Since Specialization
Citations

This map shows the geographic impact of Yingpeng Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingpeng Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingpeng Huang more than expected).

Fields of papers citing papers by Yingpeng Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingpeng Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingpeng Huang. The network helps show where Yingpeng Huang may publish in the future.

Co-authorship network of co-authors of Yingpeng Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Yingpeng Huang. A scholar is included among the top collaborators of Yingpeng Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingpeng Huang. Yingpeng Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Zhiwu, Kai Zhang, Qunying Han, et al.. (2025). Butyrate enhances recovery of chemotherapy-induced oral mucositis by enhancing tight junction protein expression and inhibiting inflammatory responses. Medicina oral, patología oral y cirugía bucal. 30(5). e657–e663.
2.
Deng, Wenhai, Shuaibin Wang, Yongyong Lu, et al.. (2025). Hyaluronic acid-modified doxorubicin-covalent organic framework nanoparticles triggered pyroptosis in combinations with immune checkpoint blockade for the treatment of breast cancer. International Journal of Biological Macromolecules. 310(Pt 3). 143265–143265. 2 indexed citations
3.
Zheng, Zhikun, Yizhou Xu, Wenhai Deng, et al.. (2025). An Fe(III)-covalent organic framework (COF)–sorafenib nanoplatform induces chemo-ferroptosis for enhanced hepatocellular carcinoma immunotherapy. Materials Today Bio. 34. 102135–102135. 4 indexed citations
4.
Wang, Xiang, Xinxin Yang, Wenhai Deng, et al.. (2024). Engineering metal-organic framework nanoparticles trigger pyroptosis to boost colon cancer immunotherapy. Materials & Design. 238. 112731–112731. 7 indexed citations
5.
Jin, Haojie, Ziheng Wu, Baofu Zhang, et al.. (2024). Glucagon-like peptide-1 receptor agonist exendin 4 ameliorates diabetes-associated vascular calcification by regulating mitophagy through the AMPK signaling pathway. Molecular Medicine. 30(1). 58–58. 10 indexed citations
7.
Song, Jingjing, Xinxin Chen, Yingpeng Huang, et al.. (2023). Genomic instability-related twelve-microRNA signatures for predicting the prognosis of gastric cancer. Computers in Biology and Medicine. 155. 106598–106598. 5 indexed citations
8.
Zhang, Yiming, et al.. (2023). LncRNA FBXO18-AS promotes gastric cancer progression by TGF-β1/Smad signaling. European Journal of Histochemistry. 67(2). 6 indexed citations
9.
Huang, Yingpeng, Jiali Zhang, Renjie Dong‬, et al.. (2021). Lactate as a metabolite from probiotic Lactobacilli mitigates ethanol-induced gastric mucosal injury: an in vivo study. BMC Complementary Medicine and Therapies. 21(1). 26–26. 13 indexed citations
10.
Shen, Xian, et al.. (2021). Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer. Frontiers in Genetics. 12. 690598–690598. 14 indexed citations
11.
Liu, Xiujie, Yaoxuan Chen, Zhihua Xu, et al.. (2021). A Meta-Analysis of Microbial Therapy Against Metabolic Syndrome: Evidence From Randomized Controlled Trials. Frontiers in Nutrition. 8. 775216–775216. 12 indexed citations
12.
Zhou, Yan, Jiajing Chen, Rui Guo, et al.. (2021). Short‑chain fatty acid butyrate: A novel shield against chronic gastric ulcer. Experimental and Therapeutic Medicine. 21(4). 329–329. 15 indexed citations
13.
Mao, Chenchen, Liangliang Ma, Yingpeng Huang, et al.. (2021). Immunogenomic Landscape and Immune-Related Gene-Based Prognostic Signature in Asian Gastric Cancer. Frontiers in Oncology. 11. 750768–750768. 6 indexed citations
14.
Liu, Xin, Xielin Huang, Dan Xiang, et al.. (2020). Overexpression of the human cytomegalovirus UL111A is correlated with favorable survival of patients with gastric cancer and changes T-cell infiltration and suppresses carcinogenesis. Journal of Cancer Research and Clinical Oncology. 146(3). 555–568. 6 indexed citations
15.
Mao, Chenchen, et al.. (2020). Concordance Between Watson for Oncology and Multidisciplinary Teams in Colorectal Cancer: Prognostic Implications and Predicting Concordance. Frontiers in Oncology. 10. 595565–595565. 2 indexed citations
16.
Zhang, Teming, Zheng Han, Xiangwei Sun, et al.. (2018). Low periostin expression predicts poor survival in intestinal type gastric cancer patients. Cancer Management and Research. Volume 11. 25–36. 5 indexed citations
17.
Lu, Mingdong, Yingpeng Huang, Weijian Sun, et al.. (2017). miR-135b-5p promotes gastric cancer progression by targeting CMTM3. International Journal of Oncology. 52(2). 589–598. 43 indexed citations
18.
Huang, Yingpeng & Ben Young. (2014). The Art of Cold-formed Steel and Aluminium Alloy Coupon Tests. 1 indexed citations
20.
Allwood, Julian M., Yingpeng Huang, & Claire Y. Barlow. (2005). Recycling scrap aluminium by cold bonding. ePrints Soton (University of Southampton). 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026